Diabetes Pathogenesis
Researchers' work adds to Diabetes Pathogenesis body of knowledge
Published in Obesity and Diabetes Week, January 9th, 2006
Study 1: In vivo leptin infusion impaired insulin and leptin signaling in the liver and hypothalamus.
According to recent research from France, "Leptin resistance contributes to the pathogenesis of common obesity related metabolic diseases, including insulin resistance. However, the relationship between leptin and insulin resistance is not clearly established."
In the present study, Y. Benomar and colleagues at the University Paris 11 in Orsay demonstrated "that induced hyperleptinemia by leptin infusion...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
High visceral fat mass amount is linked to metabolic changes in offspring of diabetics - Diet & Nutrition
Low calorie diet prevents diabetic nephropathy in the obese - Obesity Complications
Increasing BMI is strongly related to the CHD risk factors systolic blood pressure and HDL - Obesity Pathogenesis
When lipid levels are high, isoflavones fail to lower plasma triglyceride - Pediatric Diabetes
Impaired glucose tolerance and type 2 diabetes mellitus are common in obese youth - ACE Inhibitors
Angiotensin-converting enzyme inhibitors may be linked to weight maintenance in elderly - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
